[Progressive epidermal and mucosal skin lesions in a patient with rheumatoid arthritis].
Wittig
C h
Ch
Rheumaklinik und Institut für Physiotherapie mit Poliklinik, Kantonsspital Winterthur. christof.wittig@ksw.ch
Sanchez
E
E
Shirahama
J
J
Rüdt
R
R
D000284:Administration, Oral; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000633:toxicity*; D007273:Injections, Intramuscular; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000633:toxicity*; D008875:Middle Aged; D009336:Necrosis; D011241:Prednisone / Q000008:administration & dosage; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis / Q000209:etiology*; D013281:Stomatitis, Aphthous / Q000175:diagnosis / Q000209:etiology*
D007166:Immunosuppressive Agents; D011241:Prednisone; D008727:Methotrexate